147 related articles for article (PubMed ID: 26370828)
1. The use of bisphosphonate in the treatment of osteonecrosis of the femoral head: a meta-analysis of randomized control trials.
Yuan HF; Guo CA; Yan ZQ
Osteoporos Int; 2016 Jan; 27(1):295-9. PubMed ID: 26370828
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of bisphosphonates in the treatment of femoral head osteonecrosis: A PRISMA-compliant meta-analysis of animal studies and clinical trials.
Li D; Yang Z; Wei Z; Kang P
Sci Rep; 2018 Jan; 8(1):1450. PubMed ID: 29362430
[TBL] [Abstract][Full Text] [Related]
3. Intravenous bisphosphonate therapy for traumatic osteonecrosis of the femoral head in adolescents.
Ramachandran M; Ward K; Brown RR; Munns CF; Cowell CT; Little DG
J Bone Joint Surg Am; 2007 Aug; 89(8):1727-34. PubMed ID: 17671011
[TBL] [Abstract][Full Text] [Related]
4. Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: a two-year multicenter, prospective, randomized, double-blind, placebo-controlled study.
Chen CH; Chang JK; Lai KA; Hou SM; Chang CH; Wang GJ
Arthritis Rheum; 2012 May; 64(5):1572-8. PubMed ID: 22127729
[TBL] [Abstract][Full Text] [Related]
5. [Bisphosphonate treatment in osteonecrosis of the femoral head].
Nishii T; Hashimoto J; Yoshikawa H; Miki H; Sugano N
Nihon Rinsho; 2007 Nov; 65 Suppl 9():537-41. PubMed ID: 18161162
[No Abstract] [Full Text] [Related]
6. Potential for bisphosphonate treatment in Legg-Calve-Perthes disease.
Little DG; Kim HK
J Pediatr Orthop; 2011 Sep; 31(2 Suppl):S182-8. PubMed ID: 21857436
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cell therapy and other novel adjunctive therapies combined with core decompression for the treatment of osteonecrosis of the femoral head : a systematic review and meta-analysis of 20 studies.
Zhu S; Zhang X; Chen X; Wang Y; Li S; Qian W
Bone Joint Res; 2021 Jul; 10(7):445-458. PubMed ID: 34313452
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of various hip preservation treatments for non-traumatic osteonecrosis of the femoral head: A network meta-analysis of randomized controlled trials.
Yu X; Zhang D; Chen X; Yang J; Shi L; Pang Q
J Orthop Sci; 2018 Mar; 23(2):356-364. PubMed ID: 29291916
[TBL] [Abstract][Full Text] [Related]
9. Effect of bisphosphonates in preventing femoral periprosthetic bone resorption after primary cementless total hip arthroplasty: a meta-analysis.
Zhao X; Hu D; Qin J; Mohanan R; Chen L
J Orthop Surg Res; 2015 May; 10():65. PubMed ID: 25962791
[TBL] [Abstract][Full Text] [Related]
10. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study.
Lai KA; Shen WJ; Yang CY; Shao CJ; Hsu JT; Lin RM
J Bone Joint Surg Am; 2005 Oct; 87(10):2155-9. PubMed ID: 16203877
[TBL] [Abstract][Full Text] [Related]
11. Does Zoledronate Prevent Femoral Head Collapse from Osteonecrosis? A Prospective, Randomized, Open-Label, Multicenter Study.
Lee YK; Ha YC; Cho YJ; Suh KT; Kim SY; Won YY; Min BW; Yoon TR; Kim HJ; Koo KH
J Bone Joint Surg Am; 2015 Jul; 97(14):1142-8. PubMed ID: 26178889
[TBL] [Abstract][Full Text] [Related]
12. Local bisphosphonate reduces migration and formation of radiolucent lines adjacent to cemented acetabular components.
Schilcher J; Palm L; Ivarsson I; Aspenberg P
Bone Joint J; 2017 Mar; 99-B(3):317-324. PubMed ID: 28249970
[TBL] [Abstract][Full Text] [Related]
13. Early Outcomes of Primary Total Hip Arthroplasty for Osteonecrosis of the Femoral Head in Patients with Human Immunodeficiency Virus in China.
Zhao CS; Li X; Zhang Q; Sun S; Zhao RG; Cai J
Chin Med J (Engl); 2015 Aug; 128(15):2059-64. PubMed ID: 26228219
[TBL] [Abstract][Full Text] [Related]
14. Bone Loss Prevention of Bisphosphonates in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Hu Y; Chen X; Chen X; Zhang S; Jiang T; Chang J; Gao Y
Can J Gastroenterol Hepatol; 2017; 2017():2736547. PubMed ID: 28913325
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates and atrial fibrillation: systematic review and meta-analysis.
Loke YK; Jeevanantham V; Singh S
Drug Saf; 2009; 32(3):219-28. PubMed ID: 19338379
[TBL] [Abstract][Full Text] [Related]
16. Material properties of bone in the femoral head treated with ibandronate and BMP-2 following ischemic osteonecrosis.
Aruwajoye OO; Aswath PB; Kim HKW
J Orthop Res; 2017 Jul; 35(7):1453-1460. PubMed ID: 27564450
[TBL] [Abstract][Full Text] [Related]
17. The use of anticoagulants for prevention and treatment of osteonecrosis of the femoral head: A systematic review.
Guo P; Gao F; Wang Y; Zhang Z; Sun W; Jiang B; Wang B; Li Z
Medicine (Baltimore); 2017 Apr; 96(16):e6646. PubMed ID: 28422866
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of oral bisphosphonates for preventing hip fracture in disabled patients with neurological diseases: a meta-analysis of randomized controlled trials among the Japanese population.
Iwamoto J; Takeda T; Matsumoto H
Curr Med Res Opin; 2011 Jun; 27(6):1141-8. PubMed ID: 21456887
[TBL] [Abstract][Full Text] [Related]
19. One-sided hip-preserving and concurrent contralateral total hip arthroplasty for the treatment of bilateral osteonecrosis of the femoral head in different stages: short-medium term outcomes.
Zeng Y; Qi X; Feng W; Li J; Li F; Zeng J; Yi C; Chen J
BMC Musculoskelet Disord; 2015 Jun; 16():133. PubMed ID: 26040323
[TBL] [Abstract][Full Text] [Related]
20. Review of the cardiovascular safety of zoledronic acid and other bisphosphonates for the treatment of osteoporosis.
John Camm A
Clin Ther; 2010 Mar; 32(3):426-36. PubMed ID: 20399982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
